Loading…
SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors
Vaccination has been shown to stimulate remarkably high antibody levels in donors who have recovered from COVID-19. Our objective was to measure patient antibody levels before and after transfusion with COVID-19 Convalescent Plasma (CCP) and compare the antibody levels following transfusion of CCP f...
Saved in:
Published in: | Transfusion and apheresis science 2022-04, Vol.61 (2), p.103326-103326, Article 103326 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3826-c18037c7c051192b50f96b55f574aa375646fab29cbc9b32350eaa42afd7337b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c3826-c18037c7c051192b50f96b55f574aa375646fab29cbc9b32350eaa42afd7337b3 |
container_end_page | 103326 |
container_issue | 2 |
container_start_page | 103326 |
container_title | Transfusion and apheresis science |
container_volume | 61 |
creator | Leon, Judith Merrill, Anna E. Rogers, Kai Kurt, Julie Dempewolf, Spencer Ehlers, Alexandra Jackson, J. Brooks Knudson, C. Michael |
description | Vaccination has been shown to stimulate remarkably high antibody levels in donors who have recovered from COVID-19. Our objective was to measure patient antibody levels before and after transfusion with COVID-19 Convalescent Plasma (CCP) and compare the antibody levels following transfusion of CCP from vaccinated and nonvaccinated donors. Plasma samples before and after transfusion were obtained from 25 recipients of CCP and COVID-19 antibody levels measured. Factors that effect changes in antibody levels were examined. In the 21 patients who received CCP from nonvaccinated donors, modest increases in antibody levels were observed. Patients who received two units were more likely to seroconvert than those receiving just one unit. The strongest predictor of changes in patient antibody level was the CCP dose, calculated by the unit volume multiplied by the donor antibody level. Using patient plasma volume and donor antibody level, the post-transfusion antibody level could be predicted with reasonable accuracy(R2> 0.90). In contrast, the 4 patients who received CCP from vaccinated donors all had dramatic increases in antibody levels following transfusion of a single unit. In this subset of recipients, antibody levels observed after transfusion of CCP were comparable to those seen in donors who had fully recovered from COVID-19. If available, CCP from vaccinated donors with very high antibody levels should be used. One unit of CCP from vaccinated donors increases patient antibody levels much more than 1 or 2 units of CCP from unvaccinated donors. |
doi_str_mv | 10.1016/j.transci.2021.103326 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8608660</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1473050221003268</els_id><sourcerecordid>2606922801</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3826-c18037c7c051192b50f96b55f574aa375646fab29cbc9b32350eaa42afd7337b3</originalsourceid><addsrcrecordid>eNqFkctq3DAUhkVpadKkj9CiZTee6mJdvGkJk14CgUCTZiuOZXmiwZZcyWPI20fDTEO66krinP_85_Ih9IGSFSVUft6u5gQhW79ihNES45zJV-iUaqUrKjV_Xf614hURhJ2gdzlvCaGKNvItOuG1lozW5BRNtxe_bqt1vK8YhjD7NnaP2D5A2LiMfcATzN6FOePkrPOLDxu8vrm_uqxog20MCwwu2yLA0wB5BNynOOIQ0whD8evwAtb6ALPrcBdLPJ-jNz0M2b0_vmfo9_dvd-uf1fXNj6v1xXVluWayslQTrqyyRFDasFaQvpGtEL1QNQBXQtayh5Y1trVNyxkXxAHUDPpOca5afoa-HHynXTu6bj9jgsFMyY-QHk0Eb_7NBP9gNnExWhItJSkGn44GKf7ZuTyb0ZdVhwGCi7tsmCSyYUwTWqTiILUp5pxc_9yGErOnZbbmSMvsaZkDrVL38eWMz1V_8RTB14PAlUst3iVTLFywrvOFx2y66P_T4gkSeqls</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2606922801</pqid></control><display><type>article</type><title>SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors</title><source>ScienceDirect Freedom Collection</source><creator>Leon, Judith ; Merrill, Anna E. ; Rogers, Kai ; Kurt, Julie ; Dempewolf, Spencer ; Ehlers, Alexandra ; Jackson, J. Brooks ; Knudson, C. Michael</creator><creatorcontrib>Leon, Judith ; Merrill, Anna E. ; Rogers, Kai ; Kurt, Julie ; Dempewolf, Spencer ; Ehlers, Alexandra ; Jackson, J. Brooks ; Knudson, C. Michael</creatorcontrib><description>Vaccination has been shown to stimulate remarkably high antibody levels in donors who have recovered from COVID-19. Our objective was to measure patient antibody levels before and after transfusion with COVID-19 Convalescent Plasma (CCP) and compare the antibody levels following transfusion of CCP from vaccinated and nonvaccinated donors. Plasma samples before and after transfusion were obtained from 25 recipients of CCP and COVID-19 antibody levels measured. Factors that effect changes in antibody levels were examined. In the 21 patients who received CCP from nonvaccinated donors, modest increases in antibody levels were observed. Patients who received two units were more likely to seroconvert than those receiving just one unit. The strongest predictor of changes in patient antibody level was the CCP dose, calculated by the unit volume multiplied by the donor antibody level. Using patient plasma volume and donor antibody level, the post-transfusion antibody level could be predicted with reasonable accuracy(R2> 0.90). In contrast, the 4 patients who received CCP from vaccinated donors all had dramatic increases in antibody levels following transfusion of a single unit. In this subset of recipients, antibody levels observed after transfusion of CCP were comparable to those seen in donors who had fully recovered from COVID-19. If available, CCP from vaccinated donors with very high antibody levels should be used. One unit of CCP from vaccinated donors increases patient antibody levels much more than 1 or 2 units of CCP from unvaccinated donors.</description><identifier>ISSN: 1473-0502</identifier><identifier>EISSN: 1878-1683</identifier><identifier>EISSN: 1473-0502</identifier><identifier>DOI: 10.1016/j.transci.2021.103326</identifier><identifier>PMID: 34862140</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antibodies, Viral ; Blood Donors ; COVID-19 ; COVID-19 - therapy ; COVID-19 convalescent plasma (CCP) ; COVID-19 Serotherapy ; Humans ; Immunization, Passive ; SARS-CoV-2 ; Vaccinated donors</subject><ispartof>Transfusion and apheresis science, 2022-04, Vol.61 (2), p.103326-103326, Article 103326</ispartof><rights>2021</rights><rights>Copyright © 2021. Published by Elsevier Ltd.</rights><rights>Published by Elsevier Ltd. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3826-c18037c7c051192b50f96b55f574aa375646fab29cbc9b32350eaa42afd7337b3</citedby><cites>FETCH-LOGICAL-c3826-c18037c7c051192b50f96b55f574aa375646fab29cbc9b32350eaa42afd7337b3</cites><orcidid>0000-0003-3964-5466 ; 0000-0002-5945-5937 ; 0000-0003-3331-5933</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34862140$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leon, Judith</creatorcontrib><creatorcontrib>Merrill, Anna E.</creatorcontrib><creatorcontrib>Rogers, Kai</creatorcontrib><creatorcontrib>Kurt, Julie</creatorcontrib><creatorcontrib>Dempewolf, Spencer</creatorcontrib><creatorcontrib>Ehlers, Alexandra</creatorcontrib><creatorcontrib>Jackson, J. Brooks</creatorcontrib><creatorcontrib>Knudson, C. Michael</creatorcontrib><title>SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors</title><title>Transfusion and apheresis science</title><addtitle>Transfus Apher Sci</addtitle><description>Vaccination has been shown to stimulate remarkably high antibody levels in donors who have recovered from COVID-19. Our objective was to measure patient antibody levels before and after transfusion with COVID-19 Convalescent Plasma (CCP) and compare the antibody levels following transfusion of CCP from vaccinated and nonvaccinated donors. Plasma samples before and after transfusion were obtained from 25 recipients of CCP and COVID-19 antibody levels measured. Factors that effect changes in antibody levels were examined. In the 21 patients who received CCP from nonvaccinated donors, modest increases in antibody levels were observed. Patients who received two units were more likely to seroconvert than those receiving just one unit. The strongest predictor of changes in patient antibody level was the CCP dose, calculated by the unit volume multiplied by the donor antibody level. Using patient plasma volume and donor antibody level, the post-transfusion antibody level could be predicted with reasonable accuracy(R2> 0.90). In contrast, the 4 patients who received CCP from vaccinated donors all had dramatic increases in antibody levels following transfusion of a single unit. In this subset of recipients, antibody levels observed after transfusion of CCP were comparable to those seen in donors who had fully recovered from COVID-19. If available, CCP from vaccinated donors with very high antibody levels should be used. One unit of CCP from vaccinated donors increases patient antibody levels much more than 1 or 2 units of CCP from unvaccinated donors.</description><subject>Antibodies, Viral</subject><subject>Blood Donors</subject><subject>COVID-19</subject><subject>COVID-19 - therapy</subject><subject>COVID-19 convalescent plasma (CCP)</subject><subject>COVID-19 Serotherapy</subject><subject>Humans</subject><subject>Immunization, Passive</subject><subject>SARS-CoV-2</subject><subject>Vaccinated donors</subject><issn>1473-0502</issn><issn>1878-1683</issn><issn>1473-0502</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFkctq3DAUhkVpadKkj9CiZTee6mJdvGkJk14CgUCTZiuOZXmiwZZcyWPI20fDTEO66krinP_85_Ih9IGSFSVUft6u5gQhW79ihNES45zJV-iUaqUrKjV_Xf614hURhJ2gdzlvCaGKNvItOuG1lozW5BRNtxe_bqt1vK8YhjD7NnaP2D5A2LiMfcATzN6FOePkrPOLDxu8vrm_uqxog20MCwwu2yLA0wB5BNynOOIQ0whD8evwAtb6ALPrcBdLPJ-jNz0M2b0_vmfo9_dvd-uf1fXNj6v1xXVluWayslQTrqyyRFDasFaQvpGtEL1QNQBXQtayh5Y1trVNyxkXxAHUDPpOca5afoa-HHynXTu6bj9jgsFMyY-QHk0Eb_7NBP9gNnExWhItJSkGn44GKf7ZuTyb0ZdVhwGCi7tsmCSyYUwTWqTiILUp5pxc_9yGErOnZbbmSMvsaZkDrVL38eWMz1V_8RTB14PAlUst3iVTLFywrvOFx2y66P_T4gkSeqls</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Leon, Judith</creator><creator>Merrill, Anna E.</creator><creator>Rogers, Kai</creator><creator>Kurt, Julie</creator><creator>Dempewolf, Spencer</creator><creator>Ehlers, Alexandra</creator><creator>Jackson, J. Brooks</creator><creator>Knudson, C. Michael</creator><general>Elsevier Ltd</general><general>Pergamon, Elsevier Science</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3964-5466</orcidid><orcidid>https://orcid.org/0000-0002-5945-5937</orcidid><orcidid>https://orcid.org/0000-0003-3331-5933</orcidid></search><sort><creationdate>20220401</creationdate><title>SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors</title><author>Leon, Judith ; Merrill, Anna E. ; Rogers, Kai ; Kurt, Julie ; Dempewolf, Spencer ; Ehlers, Alexandra ; Jackson, J. Brooks ; Knudson, C. Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3826-c18037c7c051192b50f96b55f574aa375646fab29cbc9b32350eaa42afd7337b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibodies, Viral</topic><topic>Blood Donors</topic><topic>COVID-19</topic><topic>COVID-19 - therapy</topic><topic>COVID-19 convalescent plasma (CCP)</topic><topic>COVID-19 Serotherapy</topic><topic>Humans</topic><topic>Immunization, Passive</topic><topic>SARS-CoV-2</topic><topic>Vaccinated donors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leon, Judith</creatorcontrib><creatorcontrib>Merrill, Anna E.</creatorcontrib><creatorcontrib>Rogers, Kai</creatorcontrib><creatorcontrib>Kurt, Julie</creatorcontrib><creatorcontrib>Dempewolf, Spencer</creatorcontrib><creatorcontrib>Ehlers, Alexandra</creatorcontrib><creatorcontrib>Jackson, J. Brooks</creatorcontrib><creatorcontrib>Knudson, C. Michael</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Transfusion and apheresis science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leon, Judith</au><au>Merrill, Anna E.</au><au>Rogers, Kai</au><au>Kurt, Julie</au><au>Dempewolf, Spencer</au><au>Ehlers, Alexandra</au><au>Jackson, J. Brooks</au><au>Knudson, C. Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors</atitle><jtitle>Transfusion and apheresis science</jtitle><addtitle>Transfus Apher Sci</addtitle><date>2022-04-01</date><risdate>2022</risdate><volume>61</volume><issue>2</issue><spage>103326</spage><epage>103326</epage><pages>103326-103326</pages><artnum>103326</artnum><issn>1473-0502</issn><eissn>1878-1683</eissn><eissn>1473-0502</eissn><abstract>Vaccination has been shown to stimulate remarkably high antibody levels in donors who have recovered from COVID-19. Our objective was to measure patient antibody levels before and after transfusion with COVID-19 Convalescent Plasma (CCP) and compare the antibody levels following transfusion of CCP from vaccinated and nonvaccinated donors. Plasma samples before and after transfusion were obtained from 25 recipients of CCP and COVID-19 antibody levels measured. Factors that effect changes in antibody levels were examined. In the 21 patients who received CCP from nonvaccinated donors, modest increases in antibody levels were observed. Patients who received two units were more likely to seroconvert than those receiving just one unit. The strongest predictor of changes in patient antibody level was the CCP dose, calculated by the unit volume multiplied by the donor antibody level. Using patient plasma volume and donor antibody level, the post-transfusion antibody level could be predicted with reasonable accuracy(R2> 0.90). In contrast, the 4 patients who received CCP from vaccinated donors all had dramatic increases in antibody levels following transfusion of a single unit. In this subset of recipients, antibody levels observed after transfusion of CCP were comparable to those seen in donors who had fully recovered from COVID-19. If available, CCP from vaccinated donors with very high antibody levels should be used. One unit of CCP from vaccinated donors increases patient antibody levels much more than 1 or 2 units of CCP from unvaccinated donors.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>34862140</pmid><doi>10.1016/j.transci.2021.103326</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-3964-5466</orcidid><orcidid>https://orcid.org/0000-0002-5945-5937</orcidid><orcidid>https://orcid.org/0000-0003-3331-5933</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1473-0502 |
ispartof | Transfusion and apheresis science, 2022-04, Vol.61 (2), p.103326-103326, Article 103326 |
issn | 1473-0502 1878-1683 1473-0502 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8608660 |
source | ScienceDirect Freedom Collection |
subjects | Antibodies, Viral Blood Donors COVID-19 COVID-19 - therapy COVID-19 convalescent plasma (CCP) COVID-19 Serotherapy Humans Immunization, Passive SARS-CoV-2 Vaccinated donors |
title | SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T04%3A51%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SARS-CoV-2%20antibody%20changes%20in%20patients%20receiving%20COVID-19%20convalescent%20plasma%20from%20normal%20and%20vaccinated%20donors&rft.jtitle=Transfusion%20and%20apheresis%20science&rft.au=Leon,%20Judith&rft.date=2022-04-01&rft.volume=61&rft.issue=2&rft.spage=103326&rft.epage=103326&rft.pages=103326-103326&rft.artnum=103326&rft.issn=1473-0502&rft.eissn=1878-1683&rft_id=info:doi/10.1016/j.transci.2021.103326&rft_dat=%3Cproquest_pubme%3E2606922801%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3826-c18037c7c051192b50f96b55f574aa375646fab29cbc9b32350eaa42afd7337b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2606922801&rft_id=info:pmid/34862140&rfr_iscdi=true |